Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Schein

Showing results (41-50 of 218) with videos related to

Pageof 22
Sort By:
Biochemical Pharmacology|January 1, 1978
Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil responseB Ardalan, M D Buscaglia, P S Schein
Cancer|October 1, 1976
Cutaneous T-cell lymphomaP S Schein, J S Macdonald, R Edelson
Cancer Research|January 1, 1978
A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranoseR A Nagourney, P Fox, P S Schein
Cancer Investigation|January 1, 1991
New protective agents for bone marrow in cancer therapyW McCulloch, B J Scheffler, P S Schein
Cancer Research|May 1, 1986
Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in miceJ E Cantrell, D Green, P S Schein
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Endocrine tumorsJ J van der Hoeven, P S Schein
Cancer Research|September 1, 1973
3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicityP S Schein, M G McMenamin, T Anderson
Advances in Pharmacology and Chemotherapy|January 1, 1977
Biology, diagnosis, and chemotherapeutic management of pancreatic malignancyJ S MacDonald, L Widerlite, P S Schein
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicityJ S Macdonald, D Hoth, P S Schein
Neurology|January 1, 1971
Acute transverse myelitis associated with intravenous opiumP S Schein, L Yessayan, C I Mayman
Pageof 22

Showing results (41-50 of 218) with videos related to

Sort By:
Pageof 22
Biochemical Pharmacology|January 1, 1978
Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil responseB Ardalan, M D Buscaglia, P S Schein
Cancer|October 1, 1976
Cutaneous T-cell lymphomaP S Schein, J S Macdonald, R Edelson
Cancer Research|January 1, 1978
A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranoseR A Nagourney, P Fox, P S Schein
Cancer Investigation|January 1, 1991
New protective agents for bone marrow in cancer therapyW McCulloch, B J Scheffler, P S Schein
Cancer Research|May 1, 1986
Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in miceJ E Cantrell, D Green, P S Schein
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Endocrine tumorsJ J van der Hoeven, P S Schein
Cancer Research|September 1, 1973
3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicityP S Schein, M G McMenamin, T Anderson
Advances in Pharmacology and Chemotherapy|January 1, 1977
Biology, diagnosis, and chemotherapeutic management of pancreatic malignancyJ S MacDonald, L Widerlite, P S Schein
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicityJ S Macdonald, D Hoth, P S Schein
Neurology|January 1, 1971
Acute transverse myelitis associated with intravenous opiumP S Schein, L Yessayan, C I Mayman
Pageof 22